In response to a lawsuit that
alleged $250,000 in securities fraud
, Wakaya Perfection filed a Motion to Dismiss.

Stated reasons in the motion were for a lack of jurisdiction, or in the alternative compel the parties to resolve the matter via arbitration.

On January 14th Wakaya Perfection’s Motion to Dismiss was granted in part.

As per the January 14th order, the court ruled that all of Essence Skin Clinic’s and owner Jennifer Sannerman’s ‘
claims are covered by the arbitration provision
‘.

The provision referred to was in the investment contract she entered into.

At this time the court doesn’t appear to have taken into consideration that the contract itself might be fraudulent, only stating that

Plaintiffs’ arguments that their claims are unrelated to the arbitration provision are unpersuasive.

It is also unclear whether this will have any effect on arbitration.

In the meantime the court has stayed proceedings pending the outcome of arbitration. Stay tuned…

Update 12th April 2020 – 
The Wakaya Perfection securities fraud lawsuit was
settled through arbitration
in February 2020.

Details of the settlement between the parties has not been made public.

🤖 Quick Answer

What was the outcome of Wakaya Perfection's Motion to Dismiss filed in the securities fraud lawsuit?
On January 14th, the court granted the motion in part, ruling that all claims brought by Essence Skin Clinic and owner Jennifer Sannerman were covered by an arbitration provision contained in their investment contract, thereby compelling the parties to resolve the dispute through arbitration rather than litigation.

What allegations prompted Wakaya Perfection to file a Motion to Dismiss?
A lawsuit alleged $250,000 in securities fraud against Wakaya Perfection. The company responded by filing a motion citing lack of jurisdiction and alternatively requesting the court compel the parties to resolve the matter through arbitration proceedings.

Did the court examine the validity of the investment contract itself during the ruling?
No. The court did not consider whether the contract itself might be fraudulent in its January 14th order, focusing solely

🔗 Related Articles

- Nutra Pharma Corp settles MyNyloxin fraud with SEC
- LifeVantage granted partial class-action motion to dismiss
- BitConnect’s Craig Grant on the run from US authorities
- Massachusetts charge TelexFree as “billion dollar Ponzi”
- Faith Sloan quibbles over securities fraud, owes lawyer $50,000+